Rentokil Bromakil Super rat Drink

Hazard statements (CLP)

H373

Code

Statements

H373

May cause damage to organs through prolonged or repeated exposure

Hazard statements

This product is classified as: Not classified as hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. None allocated H373: May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

S20. When using, do not eat or drink

SUSMP Classification

S6

ADG classification

None allocated. Not a Dangerous Good

UN Number

None allocated

Signal word

WARNING

Prevention

P102: Keep out of reach of children. P264: Wash contacted areas thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P273: Avoid release to the environment.

Response

P313: Get medical advice/attention. P321: Treatment with Vitamin K1 which is antidotal, is almost always successful. P337 If eye irritation persists seek medical attention P353: Rinse skin or shower with water. P301+P330+P331 IF SWALLOWED Rinse mouth. Do NOT induce vomiting P370+P378 In case of fire Preferred extinguishing media are carbon dioxide, dry chemical, foam, water fog

Storage

P402+P404: Store in a dry place. Store in a closed container.

Disposal

P501: Dispose of contents and containers to landfill. Emergency Overview Physical Description & colour: Green viscous liquid. Odour: Mild odour.

Health hazards

Available data shows that this product is not harmful using LD50 data. However, it promotes anticoagulation (see below), and should be regarded as harmful. This product is a cumulative poison. Minor exposures over a period of time may lead to serious health problems.

Potential health effects

In most cases of ingestion of anticoagulants, victims have remained asymptomatic, due to the small dosage taken. Even in cases involving ingestion of substantial amounts of anticoagulant compound (more often medication than rodenticide), hypoprothrombinaemia has occurred without symptoms of poisoning. Haemorrhage appears only when extraordinary amounts have been absorbed. In reported cases, the anticoagulants were either taken deliberately, were absorbed over long periods out of neglect of elementary hygienic standards, or were ingested by starving indigents who used quantities of rodent bait as food. Victims of large doses exhibit haematuria, nosebleed, haematomata, bleeding gums, and melena, abdominal pain and back pain probably reflecting haemorrhage in the abdominal and retroperitoneal tissues. Weakness occurs as a result of anaemia. Renal colic often complicates severe haematuria. Nasal and gastrointestinal haemorrhages have occasionally caused death from exsanguination If poisoning is suspected, do not wait for symptoms to develop. Contact a physician, the nearest hospital, or the nearest Poison Control Center. Inhalation Short term exposure: Significant inhalation exposure is considered to be unlikely. Available data indicates that this product is not harmful by inhalation. In addition product is unlikely to cause any discomfort or irritation. Skin Contact: Short term exposure: This product may be absorbed through the skin. This is a significant exposure route. Eye Contact: Short term exposure: Exposure via eyes is considered to be unlikely. This product is believed to be not irritating to eyes. Ingestion: Short term exposure: Available data shows that this product is not harmful using LD50 data. However, it promotes anticoagulation (see above), and should be regarded as harmful. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC.